Industry Analysis & Industry Trends
The Contract Pharmaceutical Research Services industry experienced hefty growth in the past five years. Moreover, the industry is anticipated to continue its growth streak in the five years to 2020. Rising global competition during this time will limit revenue growth from achieving the double-digit rates that the industry enjoyed in the previous five years. Still, the industry's rise to prominence will transform drug development and production, securing its place in the pharmaceutical value chain.... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
The Contract Pharmaceutical Research Services industry is in the growth stage of its life cycle. Industry value-added (IVA), a measure of the industry's contribution to the overall economy, is expected to increase at an annualized 6.0% in the 10 years to 2020; meanwhile, US GDP is expected to increase at an annualized 2.5% in the same period. Industry operators are claiming a larger share of pharmaceutical companies' research and development spending, as drug producers increasingly focus on cost efficiency and quicker trial programs in the face of rising competition from generics and regulation under healthcare reform.
The industry's rapid rise comes with major shifts in downstream pharmaceutical manufacturing... purchase to read more